The Role of Immunohistochemical Analysis in the Evaluation of EML4-ALK Rearrangement Status in Lung Cancer

被引：0
|
作者：
Sullivan, H. C. [1 ]
Siddiqui, M. T. [1 ]
Wang, J. [1 ]
Cohen, C. [1 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1945
引用
收藏
页码：468A / 468A
页数：1
相关论文
共 50 条
  • [1] The Role of Immunohistochemical Analysis in the Evaluation of EML4-ALK Rearrangement Status in Lung Cancer
    Sullivan, H. C.
    Siddiqui, M. T.
    Wang, J.
    Cohen, C.
    MODERN PATHOLOGY, 2013, 26 : 468A - 468A
  • [2] The Role of Immunohistochemical Analysis in the Evaluation of EML4-ALK Gene Rearrangement in Lung Cancer
    Sullivan, Harold C.
    Fisher, Kevin E.
    Hoffa, Anne L.
    Wang, Jason
    Saxe, Debra
    Siddiqui, Momin T.
    Cohen, Cynthia
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2015, 23 (04) : 239 - 244
  • [3] Endometrial cancer with an EML4-ALK rearrangement
    Craig, Jeffrey W.
    Quade, Bradley J.
    Muto, Michael G.
    MacConaill, Laura E.
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2018, 4 (04):
  • [4] Endobronchial Metastases in Lung Cancer Harboring EML4-ALK Rearrangement
    Ijichi, Miharu
    Fukuda, Yosuke
    Kashima, Ayaka
    Sagara, Hironori
    INTERNAL MEDICINE, 2023, 62 (13) : 2021 - 2022
  • [5] Analysis of EML4-ALK rearrangement in non-small cell lung cancer in Argentina
    Verzura, Maria
    Batagelj, Emilio
    Bagnes, Claudia
    Martin, Claudio
    Enrico, Diego
    Richardet, Eduardo
    De la Iglesia, Paola
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 34 : 77 - 81
  • [6] MONO INSTITUTIONAL EXPERIENCE IN NON SMALL LUNG CANCER WITH EML4-ALK REARRANGEMENT
    Perez Mesa, Pablo Jose
    Guadalupe Pallotta, Maria
    De La Iglesia, Paola
    Lupinacci, Lorena
    Liliana Dalurzo, Mercedes
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S170 - S170
  • [7] EML4-ALK Fusion in Lung
    Mano, Hiroyuki
    Takeuchi, Kengo
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (03): : 1552 - 1553
  • [8] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Bilgin, Burak
    Sendur, Mehmet Ali Nahit
    Yucel, Sebnem
    Hizal, Mutlu
    Guner, Gurkan
    Akyurek, Nalan
    Erol, Cihan
    Akinci, Muhammed Bulent
    Dede, Didem Sener
    Yalcin, Bulent
    Kilickap, Sadettin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2637 - 2643
  • [9] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Burak Bilgin
    Mehmet Ali Nahit Şendur
    Şebnem Yücel
    Mutlu Hizal
    Gürkan Güner
    Nalan Akyürek
    Cihan Erol
    Muhammed Bülent Akıncı
    Didem Şener Dede
    Bülent Yalçın
    Sadettin Kılıçkap
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2637 - 2643
  • [10] Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant
    To, Ka-Fai
    Tong, Joanna H. M.
    Yeung, King S. F.
    Lung, Raymond W. M.
    Law, Peggy P. Y.
    Chau, Shuk Ling
    Kang, Wei
    Tong, Carol Y. K.
    Chow, Chit
    Chan, Anthony W. H.
    Leung, Linda K. S.
    Mok, Tony S. K.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : 883 - 891
12345